オピオイド誘発性便秘（OIC）治療の世界市場（～2026年）

• 英文タイトル：Global Opioid-Induced Constipation (OIC) Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04062
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料はオピオイド誘発性便秘（OIC）治療のグローバル市場について調査・分析したレポートです。種類別（経口、非経口（皮下注射））市場規模、用途別（ドラッグストア、独立型薬局、病院薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別オピオイド誘発性便秘（OIC）治療の競争状況、市場シェア
・世界のオピオイド誘発性便秘（OIC）治療市場：種類別市場規模 2015年-2020年（経口、非経口（皮下注射））
・世界のオピオイド誘発性便秘（OIC）治療市場：種類別市場規模予測 2021年-2026年（経口、非経口（皮下注射））
・世界のオピオイド誘発性便秘（OIC）治療市場：用途別市場規模 2015年-2020年（ドラッグストア、独立型薬局、病院薬局）
・世界のオピオイド誘発性便秘（OIC）治療市場：用途別市場規模予測 2021年-2026年（ドラッグストア、独立型薬局、病院薬局）
・北米のオピオイド誘発性便秘（OIC）治療市場分析：米国、カナダ
・ヨーロッパのオピオイド誘発性便秘（OIC）治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのオピオイド誘発性便秘（OIC）治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のオピオイド誘発性便秘（OIC）治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのオピオイド誘発性便秘（OIC）治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：GlaxoSmithKline、AstraZeneca、Pfizer、S.L.A. Pharma、AIKO Biotechnology、Cubist Pharmaceuticals、Salix Pharmaceuticals、Takeda Pharmaceutical
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Opioid-Induced Constipation (OIC) Treatment Market
The global Opioid-Induced Constipation (OIC) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Opioid-Induced Constipation (OIC) Treatment Scope and Market Size
Opioid-Induced Constipation (OIC) Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Opioid-Induced Constipation (OIC) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
GlaxoSmithKline
AstraZeneca
Pfizer
S.L.A. Pharma
AIKO Biotechnology
Cubist Pharmaceuticals
Salix Pharmaceuticals
Takeda Pharmaceutical

Market segment by Type, the product can be split into
Oral
Parenteral (Subcutaneous Injection)
Market segment by Application, split into
Drug Store
Independent Pharmacies
Hospital Pharmacies

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Opioid-Induced Constipation (OIC) Treatment Revenue
1.4 Market by Type
1.4.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Parenteral (Subcutaneous Injection)
1.5 Market by Application
1.5.1 Global Opioid-Induced Constipation (OIC) Treatment Market Share by Application: 2020 VS 2026
1.5.2 Drug Store
1.5.3 Independent Pharmacies
1.5.4 Hospital Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Perspective (2015-2026)
2.2 Global Opioid-Induced Constipation (OIC) Treatment Growth Trends by Regions
2.2.1 Opioid-Induced Constipation (OIC) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Opioid-Induced Constipation (OIC) Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Opioid-Induced Constipation (OIC) Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Opioid-Induced Constipation (OIC) Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Opioid-Induced Constipation (OIC) Treatment Players by Market Size
3.1.1 Global Top Opioid-Induced Constipation (OIC) Treatment Players by Revenue (2015-2020)
3.1.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Opioid-Induced Constipation (OIC) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Opioid-Induced Constipation (OIC) Treatment Market Concentration Ratio
3.2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Opioid-Induced Constipation (OIC) Treatment Revenue in 2019
3.3 Opioid-Induced Constipation (OIC) Treatment Key Players Head office and Area Served
3.4 Key Players Opioid-Induced Constipation (OIC) Treatment Product Solution and Service
3.5 Date of Enter into Opioid-Induced Constipation (OIC) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Opioid-Induced Constipation (OIC) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2015-2020)
5.2 Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size (2015-2020)
6.2 Opioid-Induced Constipation (OIC) Treatment Key Players in North America (2019-2020)
6.3 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2015-2020)
6.4 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size (2015-2020)
7.2 Opioid-Induced Constipation (OIC) Treatment Key Players in Europe (2019-2020)
7.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2015-2020)
7.4 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2015-2020)

8 China
8.1 China Opioid-Induced Constipation (OIC) Treatment Market Size (2015-2020)
8.2 Opioid-Induced Constipation (OIC) Treatment Key Players in China (2019-2020)
8.3 China Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2015-2020)
8.4 China Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Opioid-Induced Constipation (OIC) Treatment Market Size (2015-2020)
9.2 Opioid-Induced Constipation (OIC) Treatment Key Players in Japan (2019-2020)
9.3 Japan Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2015-2020)
9.4 Japan Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Size (2015-2020)
10.2 Opioid-Induced Constipation (OIC) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2015-2020)

11 India
11.1 India Opioid-Induced Constipation (OIC) Treatment Market Size (2015-2020)
11.2 Opioid-Induced Constipation (OIC) Treatment Key Players in India (2019-2020)
11.3 India Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2015-2020)
11.4 India Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Opioid-Induced Constipation (OIC) Treatment Market Size (2015-2020)
12.2 Opioid-Induced Constipation (OIC) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Introduction
13.1.4 GlaxoSmithKline Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 AstraZeneca
13.2.1 AstraZeneca Company Details
13.2.2 AstraZeneca Business Overview
13.2.3 AstraZeneca Opioid-Induced Constipation (OIC) Treatment Introduction
13.2.4 AstraZeneca Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2015-2020)
13.2.5 AstraZeneca Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Opioid-Induced Constipation (OIC) Treatment Introduction
13.3.4 Pfizer Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 S.L.A. Pharma
13.4.1 S.L.A. Pharma Company Details
13.4.2 S.L.A. Pharma Business Overview
13.4.3 S.L.A. Pharma Opioid-Induced Constipation (OIC) Treatment Introduction
13.4.4 S.L.A. Pharma Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2015-2020)
13.4.5 S.L.A. Pharma Recent Development
13.5 AIKO Biotechnology
13.5.1 AIKO Biotechnology Company Details
13.5.2 AIKO Biotechnology Business Overview
13.5.3 AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Introduction
13.5.4 AIKO Biotechnology Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2015-2020)
13.5.5 AIKO Biotechnology Recent Development
13.6 Cubist Pharmaceuticals
13.6.1 Cubist Pharmaceuticals Company Details
13.6.2 Cubist Pharmaceuticals Business Overview
13.6.3 Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Introduction
13.6.4 Cubist Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2015-2020)
13.6.5 Cubist Pharmaceuticals Recent Development
13.7 Salix Pharmaceuticals
13.7.1 Salix Pharmaceuticals Company Details
13.7.2 Salix Pharmaceuticals Business Overview
13.7.3 Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Introduction
13.7.4 Salix Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2015-2020)
13.7.5 Salix Pharmaceuticals Recent Development
13.8 Takeda Pharmaceutical
13.8.1 Takeda Pharmaceutical Company Details
13.8.2 Takeda Pharmaceutical Business Overview
13.8.3 Takeda Pharmaceutical Opioid-Induced Constipation (OIC) Treatment Introduction
13.8.4 Takeda Pharmaceutical Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2015-2020)
13.8.5 Takeda Pharmaceutical Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Opioid-Induced Constipation (OIC) Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Opioid-Induced Constipation (OIC) Treatment Revenue
Table 3. Ranking of Global Top Opioid-Induced Constipation (OIC) Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Parenteral (Subcutaneous Injection)
Table 7. Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Regions (2015-2020)
Table 11. Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Opioid-Induced Constipation (OIC) Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Opioid-Induced Constipation (OIC) Treatment Players
Table 18. Global Opioid-Induced Constipation (OIC) Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Players (2015-2020)
Table 20. Global Top Opioid-Induced Constipation (OIC) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid-Induced Constipation (OIC) Treatment as of 2019)
Table 21. Global Opioid-Induced Constipation (OIC) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Opioid-Induced Constipation (OIC) Treatment Product Solution and Service
Table 24. Date of Enter into Opioid-Induced Constipation (OIC) Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Opioid-Induced Constipation (OIC) Treatment Market Size Share by Type (2015-2020)
Table 28. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Opioid-Induced Constipation (OIC) Treatment Market Size Share by Application (2015-2020)
Table 30. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Opioid-Induced Constipation (OIC) Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Opioid-Induced Constipation (OIC) Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Opioid-Induced Constipation (OIC) Treatment Market Share (2019-2020)
Table 34. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2015-2020)
Table 36. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Opioid-Induced Constipation (OIC) Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Opioid-Induced Constipation (OIC) Treatment Market Share (2019-2020)
Table 40. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2015-2020)
Table 42. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Opioid-Induced Constipation (OIC) Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Opioid-Induced Constipation (OIC) Treatment Market Share (2019-2020)
Table 46. China Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2015-2020)
Table 48. China Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Opioid-Induced Constipation (OIC) Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Opioid-Induced Constipation (OIC) Treatment Market Share (2019-2020)
Table 52. Japan Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2015-2020)
Table 54. Japan Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Opioid-Induced Constipation (OIC) Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Opioid-Induced Constipation (OIC) Treatment Market Share (2019-2020)
Table 58. Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Opioid-Induced Constipation (OIC) Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Opioid-Induced Constipation (OIC) Treatment Market Share (2019-2020)
Table 64. India Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2015-2020)
Table 66. India Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Opioid-Induced Constipation (OIC) Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Opioid-Induced Constipation (OIC) Treatment Market Share (2019-2020)
Table 70. Central & South America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2015-2020)
Table 74. GlaxoSmithKline Company Details
Table 75. GlaxoSmithKline Business Overview
Table 76. GlaxoSmithKline Product
Table 77. GlaxoSmithKline Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2015-2020) (Million US$)
Table 78. GlaxoSmithKline Recent Development
Table 79. AstraZeneca Company Details
Table 80. AstraZeneca Business Overview
Table 81. AstraZeneca Product
Table 82. AstraZeneca Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2015-2020) (Million US$)
Table 83. AstraZeneca Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Product
Table 87. Pfizer Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2015-2020) (Million US$)
Table 88. Pfizer Recent Development
Table 89. S.L.A. Pharma Company Details
Table 90. S.L.A. Pharma Business Overview
Table 91. S.L.A. Pharma Product
Table 92. S.L.A. Pharma Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2015-2020) (Million US$)
Table 93. S.L.A. Pharma Recent Development
Table 94. AIKO Biotechnology Company Details
Table 95. AIKO Biotechnology Business Overview
Table 96. AIKO Biotechnology Product
Table 97. AIKO Biotechnology Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2015-2020) (Million US$)
Table 98. AIKO Biotechnology Recent Development
Table 99. Cubist Pharmaceuticals Company Details
Table 100. Cubist Pharmaceuticals Business Overview
Table 101. Cubist Pharmaceuticals Product
Table 102. Cubist Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2015-2020) (Million US$)
Table 103. Cubist Pharmaceuticals Recent Development
Table 104. Salix Pharmaceuticals Company Details
Table 105. Salix Pharmaceuticals Business Overview
Table 106. Salix Pharmaceuticals Product
Table 107. Salix Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2015-2020) (Million US$)
Table 108. Salix Pharmaceuticals Recent Development
Table 109. Takeda Pharmaceutical Business Overview
Table 110. Takeda Pharmaceutical Product
Table 111. Takeda Pharmaceutical Company Details
Table 112. Takeda Pharmaceutical Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2015-2020) (Million US$)
Table 113. Takeda Pharmaceutical Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Parenteral (Subcutaneous Injection) Features
Figure 4. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Application: 2020 VS 2026
Figure 5. Drug Store Case Studies
Figure 6. Independent Pharmacies Case Studies
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Opioid-Induced Constipation (OIC) Treatment Report Years Considered
Figure 9. Global Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Players in 2019
Figure 14. Global Top Opioid-Induced Constipation (OIC) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid-Induced Constipation (OIC) Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Opioid-Induced Constipation (OIC) Treatment Revenue in 2019
Figure 16. North America Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed

以下、関連資料のご紹介

オピオイド誘発性便秘治療の世界市場（～2026年）

Global Opioid Induced Constipation Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04061 2020年11月20日 91Pages
当調査資料はオピオイド誘発性便秘治療のグローバル市場について調査・分析したレポートです。種類別（経口、非経口（皮下注射））市場規模、用途別（ドラッグストア、独立型薬局、病院薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、...

オピオイド誘発性便秘（OIC）治療薬の世界市場（～2026年）

Global Opioid Induced Constipation (OIC) Drug Market Insights and Forecast to 2026
MRC2-11QY08386 2020年11月20日 150Pages
当調査資料はオピオイド誘発性便秘（OIC）治療薬のグローバル市場について調査・分析したレポートです。種類別（ルビプロストン、臭化メチルナルトレキソン、ナルデメジン、アルビモパン、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フ...

化学療法薬誘発性肢端紅斑（手足症候群）治療の世界市場（～2026年）

Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11343 2020年11月25日 92Pages
当調査資料は化学療法薬誘発性肢端紅斑（手足症候群）治療のグローバル市場について調査・分析したレポートです。種類別（鎮痛剤、抗炎症剤・抗浮腫剤、抗ヒスタミン剤、NSAID、経口/局所グルココルチコイド、ピリドキシン（ビタミンB6）、その他）市場規模、用途別（薬局・ドラッグストア、病院薬局、オンラインド...

便秘治療の世界市場（～2026年）

Global Constipation Treatment Market Insights and Forecast to 2026
MRC2-11QY00576 2020年11月20日 151Pages
当調査資料は便秘治療のグローバル市場について調査・分析したレポートです。種類別（慢性特発性便秘、便秘伴う過敏性腸症候群、オピオイド誘発性便秘）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、...

便秘の世界市場（～2026年）

Global Constipation Market Size, Status and Forecast 2020-2026
MRC2-11QY11482 2020年11月25日 126Pages
当調査資料は便秘のグローバル市場について調査・分析したレポートです。種類別（慢性特発性便秘（CIC）、過敏性腸症候群（IBS-C）、オピオイド誘発性便秘（OIC））市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタ...

脊髄性筋萎縮症（SMA）治療の世界市場（～2026年）

Global Spinal Muscular Atrophy (SMA) Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04710 2020年11月20日 91Pages
当調査資料は脊髄性筋萎縮症（SMA）治療のグローバル市場について調査・分析したレポートです。種類別（I型脊髄性筋萎縮症（SMA）、II型脊髄性筋萎縮症（SMA）、III型脊髄性筋萎縮症（SMA））市場規模、用途別（病院、外来外科センター、診断センター、その他）市場規模、地域別（北米、米国、カナダ、ヨ...

多形性膠芽腫（GBM）治療の世界市場（～2026年）

Global Glioblastoma Multiforme Treatment (GBM) Market Size, Status and Forecast 2020-2026
MRC2-11QY12056 2020年11月25日 92Pages
当調査資料は多形性膠芽腫（GBM）治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、遺伝子治療、分子バイオテクノロジー）市場規模、用途別（ベバコズマブ、カルムスチン、テモゾロミド）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリ...

化学療法好中球減少症治療の世界市場（～2026年）

Global Chemotherapy-Induced Neutropenia Treatment Market Insights and Forecast to 2026
MRC2-11QY00179 2020年11月20日 115Pages
当調査資料は化学療法好中球減少症治療のグローバル市場について調査・分析したレポートです。種類別（抗生物質療法、コロニー刺激因子療法、顆粒球輸血、脾臓摘出術、その他）市場規模、用途別（病院、外来外科センター、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イ...

糖尿病網膜症（DR）治療の世界市場（～2026年）

Global Diabetic Retinopathy Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11638 2020年11月25日 125Pages
当調査資料は糖尿病網膜症（DR）治療のグローバル市場について調査・分析したレポートです。種類別（増殖性糖尿病性網膜症（PDR）、非増殖性糖尿病性網膜症（NPDR））市場規模、用途別（眼科クリニック、外来手術センター、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イ...

自閉症スペクトラム障害（ASD）治療の世界市場（～2026年）

Global Autism Spectrum Disorder (ASD) Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY10928 2020年11月25日 94Pages
当調査資料は自閉症スペクトラム障害（ASD）治療のグローバル市場について調査・分析したレポートです。種類別（自閉症、アスペルガー症候群、広汎性発達障害、小児期崩壊性障害）市場規模、用途別（病院・クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア...

オピオイド誘発性便秘治療の世界市場（～2026年） There are multiple drugs in the pipeline for opioid induced constipation treatment. Upon approval, these drugs will face little competition in this market which is largely untapped. There have not been many stable choices in the pharmaceutical industry for opioid induced constipation treatment over …
オピオイド誘発性便秘（OIC）治療薬の世界市場（～2026年） Opioid-induced constipation (OIC) is a common adverse effect experienced by many patients on opioid therapy for chronic pain. OTC medications include stimulant laxatives, stool softeners, and enemas. Market Analysis and Insights: Global Opioid Induced Constipation (OIC) Drug Market The global Opioid…
便秘治療の世界市場（～2026年） Constipation refers to bowel movements that are infrequent or hard to pass. The stool is often hard and dry. Other symptoms may include abdominal pain, bloating, and feeling as if one has not completely passed the bowel movement. Market Analysis and Insights: Global Constipation Treatment Market The…
便秘の世界市場（～2026年） Constipation is common disease which is estimated to affect each individual once in life time. According to international as well regional guidelines it is characterized by frequency and nature of bowel movement. Less than 2 bowel movements per week, associated with hard stool and strain in passing …
化学療法薬誘発性肢端紅斑（手足症候群）治療の世界市場（～2026年） Acral erythema, also called as hand-foot syndrome or palmar-plantar erythrodysesthesia, is characterized by swelling, redness, paraesthesia (numbness) and desquamation (skin peeling) of palms, soles and rarely on knees and elbow. Acryl erythema is an adverse drug reaction which typically appear afte…